[Endocrine effect of L-DOPA in treating the amenorrhea-galactorrhea syndrome].
L-DOPA effect on the level of dopamine, hypophyseal luteinizing hormone and total estrogen excretion was studied in the treatment of patients with the amenorrhea-galactorrhea syndrome. The data obtained show positive L-DOPA effect on hypothalamic-hypophyseal-ovarian relationships in the majority of patients that makes it useful in therapeutic practice. The short-term course of L-DOPA administration combined with systematic studies of dopamine and hypophyseal luteinizing hormone excretion may be recommended as a functional test for differential diagnosis of central menstrual dysfunction.
D000328:Adult; D000568:Amenorrhea / Q000188:drug therapy*; D002908:Chronic Disease; D004298:Dopamine / Q000652:urine; D004967:Estrogens / Q000652:urine; D005260:Female; D005687:Galactorrhea / Q000188:drug therapy*; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects*; D007775:Lactation Disorders / Q000188:drug therapy*; D007980:Levodopa / Q000627:therapeutic use*; D007986:Luteinizing Hormone / Q000652:urine; D010053:Ovary / Q000187:drug effects*; D011247:Pregnancy; D013577:Syndrome; D013997:Time Factors
D004967:Estrogens; D007980:Levodopa; D007986:Luteinizing Hormone; D004298:Dopamine
Endokrinnyĭ éffekt L-DOFA pri lechenii bol'nykh s sindromom amenorei-galaktorei.